Agios Pharmaceuticals AGIO Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's interest coverage?
- Agios Pharmaceuticals (AGIO) reported interest coverage of -9.3× in Q1 2026.
- How has Agios Pharmaceuticals's interest coverage changed year-over-year?
- Agios Pharmaceuticals's interest coverage decreased by 16.9% year-over-year, from -8× to -9.3×.
- What is the long-term trend for Agios Pharmaceuticals's interest coverage?
- Over 3 years (2021 to 2025), Agios Pharmaceuticals's interest coverage has grown at a -73.6% compound annual growth rate (CAGR), from -452.7× to -8.4×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.